Silence Therapeutics plc (SLNCF) Total liabilities 2023–2025
Silence Therapeutics plc (SLNCF) total liabilities at each fiscal year-end, per SEC filings.
$69.1MFY2025 · since FY2023: $97.5M → $69.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $69.1M | +0.8% |
| FY2024 | $68.6M | -29.6% |
| FY2023 | $97.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More SLNCF financial trends
SLNCF RevenueSLNCF Net incomeSLNCF Net marginSLNCF Gross profitSLNCF Gross marginSLNCF Operating incomeSLNCF Operating marginSLNCF Operating cash flowSLNCF Free cash flowSLNCF Capital expendituresSLNCF Return on equitySLNCF Stock buybacksSLNCF Dividends paidSLNCF Total assetsSLNCF Shareholders’ equitySLNCF overview →